These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 9079240)

  • 21. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
    Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
    Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 4th communication: tissue distribution, placental transfer and milk secretion of radioactivity in rats after a single oral administration of 14C-NS-49, and effects of repeated administration on its pharmacokinetics.
    Dalrymple PD; Beeby TL; Mukai H; Chasseaud LF
    Arzneimittelforschung; 2001; 51(5):394-401. PubMed ID: 11413740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
    Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
    Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic fate of the new anti-ulcer drug enprostil in animals. 3rd communication: tissue accumulation after consecutive oral administration of [3H]-enprostil in rats.
    Kohno M; Naito K; Yamada Y; Nakahara M; Otsuka M; Takaiti O; Parnes H; Chaplin M
    Arzneimittelforschung; 1989 Mar; 39(3):350-6. PubMed ID: 2502988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
    Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
    Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs.
    Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L
    Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic fate of the new cardiotonic denopamine in animals. 2nd communication: tissue accumulation in the rat after consecutive oral administration of 14C-denopamine.
    Naito K; Furuuchi S; Usuki S; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):652-5. PubMed ID: 3718589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
    Siefert HM; Maruhn D; Scholl H
    Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biotransformation of a new synthetic retinoid, 4-[(5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid (Am-80), in the rat. Structure elucidation of the metabolites by mass and nmr spectrometry.
    Hashimoto S; Mizobuchi M; Kuroda T; Okabe H; Mizojiri K; Takahashi S; Kikuchi J; Terui Y
    Xenobiotica; 1994 Dec; 24(12):1177-93. PubMed ID: 7771105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
    Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
    Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-dose kinetics of tissue distribution, excretion and metabolism of amiodarone in rats.
    Wyss PA; Moor MJ; Bickel MH
    J Pharmacol Exp Ther; 1990 Aug; 254(2):502-7. PubMed ID: 2384884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in rats.
    Cho YB; Kim DK; Kim KH; Miyamoto G
    Arzneimittelforschung; 1996 Jun; 46(6):629-34. PubMed ID: 8767356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.